Scholarly Works

In active lupus nephritis, adding obinutuzumab to...

Journal article

In active lupus nephritis, adding obinutuzumab to standard therapy increased complete renal response rates at 76 wk.

Abstract

CLINICAL IMPACT RATINGS: GIM/FP/GP: [Formula: see text] Nephrology: [Formula: see text] Rheumatology: [Formula: see text].

Authors

Molnar AO

Journal

Annals of Internal Medicine, Vol. 178, No. 6,

Publisher

American College of Physicians

Publication Date

June 1, 2025

DOI

10.7326/annals-25-01947-jc

ISSN

1056-8751

Associated Experts

Amber Molnar

Associate Professor, Faculty of Health Sciences

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3202 Clinical Sciences

View published work (Non-McMaster Users)

View published work (McMaster Users)

Contact the Experts team

Get technical help

or

Provide website feedback